Xiangpeng Dai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xiangpeng Dai has a total of 138 co-authors. Here are the top co-authors by number of shared publications:
- Xiaoling Zhang
Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital of Jilin University
15 shared publications Luyao Wang
Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital of Jilin University, Changchun, China
10 shared publicationsYurong Chen
Reproductive Medicine Center, Xiamen University Affiliated Chenggong Hospital, Xiamen, China
9 shared publicationsFucheng Guo
Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital of Jilin University, Changchun, China
7 shared publicationsTong Zhang
Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital of Jilin University, Changchun, China
6 shared publicationsJiarui Wei
Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital of Jilin University, Changchun, China; National-Local Joint Engineering Laboratory of Animal Models for Human Disease, First Hospital of Jilin University, Changchun, China
4 shared publications
Latest Publications
- 22 October 2026
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 321
Design, synthesis, and antitumor evaluation of novel VEGFR-2/BRD4 dual inhibitors with potent in vivo efficacy
- 22 October 2026
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 321
Design, synthesis, and antitumor evaluation of novel VEGFR-2/BRD4 dual inhibitors with potent in vivo efficacy
- Open Access
- 25 September 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1960932
Cancer degronopathies and protein-fate biomarkers in drug resistance and cancer progression: signalling mechanisms, measurement and translational limits
Drug resistance remains a major barrier to durable targeted therapy, and cancer progression often reflects rewiring of signalling pathways that control protein stability. Dysregulation of the ubiquitin–proteasome system, including failure of degron-dependent substrate recognition, can stabilise oncogenic proteins, accelerate tumour-suppressor loss and generate treatment-dependent protein states. Yet clinical interpretation commonly relies on genotype or steady-state abundance, neither of which directly identifies the degradation rate or route of a specific substrate. In this critical narrative review, we use cancer degronopathy as a restricted operational term for tumour-relevant alterations in degron-dependent recognition, rather than as an established disease or diagnostic class. Through contrastive analysis of four endogenous modules (SPOP; FBXW7 versus CTNNB1; KEAP1–NFE2L2–CUL3; and VHL–HIF), together with drug-induced degradation, we examine how altered protein fate intersects with signalling pathways implicated in cancer progression, intrinsic or acquired drug resistance and therapeutic response. We trace each candidate biomarker from the initiating tumour event and substrate-specific fate change to patient-compatible measurement, analytical performance and intended clinical use. The analysis shows that SPOP effects vary with allele, substrate, lineage and assembly; FBXW7 reader defects and CTNNB1 cis-acting escape require different analytes; and pooled KEAP1-axis states and cross-isoform VHL–HIF extrapolations remain unresolved. Pharmacological degradation adds a temporal layer: vepdegestrant acts through oestrogen receptor-α degradation, whereas its FDA-authorised companion diagnostic selects patients by plasma ESR1 genotype, and serial target measurements are required to distinguish productive target loss, failed loss, recovery and downstream escape. Protein-fate measurement may be informative if it resolves a reproducible, decision-relevant state that genotype, abundance or pathway-output markers leave ambiguous. We define the experimental and clinical evidence needed to test whether such measurements can inform precision strategies to address drug resistance and cancer progression. Conclusion remain limited to the contrastive cases and United States records reviewed through 26 July 2026, with separately dated updates to selected trial records.
- 25 September 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1960932
Open AccessCancer degronopathies and protein-fate biomarkers in drug resistance and cancer progression: signalling mechanisms, measurement and translational limits
Drug resistance remains a major barrier to durable targeted therapy, and cancer progression often reflects rewiring of signalling pathways that control protein stability. Dysregulation of the ubiquitin–proteasome system, including failure of degron-dependent substrate recognition, can stabilise oncogenic proteins, accelerate tumour-suppressor loss and generate treatment-dependent protein states. Yet clinical interpretation commonly relies on genotype or steady-state abundance, neither of which directly identifies the degradation rate or route of a specific substrate. In this critical narrative review, we use cancer degronopathy as a restricted operational term for tumour-relevant alterations in degron-dependent recognition, rather than as an established disease or diagnostic class. Through contrastive analysis of four endogenous modules (SPOP; FBXW7 versus CTNNB1; KEAP1–NFE2L2–CUL3; and VHL–HIF), together with drug-induced degradation, we examine how altered protein fate intersects with signalling pathways implicated in cancer progression, intrinsic or acquired drug resistance and therapeutic response. We trace each candidate biomarker from the initiating tumour event and substrate-specific fate change to patient-compatible measurement, analytical performance and intended clinical use. The analysis shows that SPOP effects vary with allele, substrate, lineage and assembly; FBXW7 reader defects and CTNNB1 cis-acting escape require different analytes; and pooled KEAP1-axis states and cross-isoform VHL–HIF extrapolations remain unresolved. Pharmacological degradation adds a temporal layer: vepdegestrant acts through oestrogen receptor-α degradation, whereas its FDA-authorised companion diagnostic selects patients by plasma ESR1 genotype, and serial target measurements are required to distinguish productive target loss, failed loss, recovery and downstream escape. Protein-fate measurement may be informative if it resolves a reproducible, decision-relevant state that genotype, abundance or pathway-output markers leave ambiguous. We define the experimental and clinical evidence needed to test whether such measurements can inform precision strategies to address drug resistance and cancer progression. Conclusion remain limited to the contrastive cases and United States records reviewed through 26 July 2026, with separately dated updates to selected trial records.
- Open Access
- 10 September 2026
- Published by Springer Nature in Cell Communication and Signaling
HSPA5 enhances the survival rate of human cells by protecting mesenchymal stem cells from heat stress
- 10 September 2026
- Published by Springer Nature in Cell Communication and Signaling
Open AccessHSPA5 enhances the survival rate of human cells by protecting mesenchymal stem cells from heat stress
- Open Access
- 5 August 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1906115
OTULIN: a master regulator of linear ubiquitin homeostasis in immune signaling, inflammation, and disease
OTU deubiquitinase with linear linkage specificity (OTULIN) is the only deubiquitinase known to exhibit strict specificity for Met1-linked linear ubiquitin chains, serving as a critical regulator that restrains linear ubiquitin chain assembly complex and maintains inflammatory homeostasis and tissue integrity. Advances over recent years have reshaped our understanding of OTULIN from a negative regulator confined to the canonical nuclear factor kappa-light-chain-enhancer of activated B cells pathway to a central editor governing linear ubiquitin network homeostasis. Its functional repertoire spans receptor-proximal inflammatory signaling, cell death fate determination, inflammasome activation, autophagy, and cellular stress adaptation. Emerging evidence from human genetics and animal models has further broadened the OTULIN-associated disease spectrum, revealing that pathogenesis arises from imbalanced linear ubiquitin networks coupled with cell type and tissue context dependent inflammatory dysregulation. Here, we provide a comprehensive overview of OTULIN’s structural features, regulatory mechanisms, biological functions, roles in pathogenesis, and potential therapeutic intervention strategies, aiming to inform future mechanistic studies and facilitate translational advances in targeted therapies.
- 5 August 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1906115
Open AccessOTULIN: a master regulator of linear ubiquitin homeostasis in immune signaling, inflammation, and disease
OTU deubiquitinase with linear linkage specificity (OTULIN) is the only deubiquitinase known to exhibit strict specificity for Met1-linked linear ubiquitin chains, serving as a critical regulator that restrains linear ubiquitin chain assembly complex and maintains inflammatory homeostasis and tissue integrity. Advances over recent years have reshaped our understanding of OTULIN from a negative regulator confined to the canonical nuclear factor kappa-light-chain-enhancer of activated B cells pathway to a central editor governing linear ubiquitin network homeostasis. Its functional repertoire spans receptor-proximal inflammatory signaling, cell death fate determination, inflammasome activation, autophagy, and cellular stress adaptation. Emerging evidence from human genetics and animal models has further broadened the OTULIN-associated disease spectrum, revealing that pathogenesis arises from imbalanced linear ubiquitin networks coupled with cell type and tissue context dependent inflammatory dysregulation. Here, we provide a comprehensive overview of OTULIN’s structural features, regulatory mechanisms, biological functions, roles in pathogenesis, and potential therapeutic intervention strategies, aiming to inform future mechanistic studies and facilitate translational advances in targeted therapies.
- Open Access
- 8 June 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
CUL7-mediated KEAP1 ubiquitination promotes the progression of colon cancer via NRF2 signaling
Cullin7 (CUL7) mediates cancer progression across multiple cancer types through its regulatory role in protein ubiquitination. However, the biological function and molecular mechanisms underlying CUL7 in colon cancer remain poorly defined. Here, we demonstrate that high CUL7 expression correlates with poor prognosis in patients. Ablation of CUL7 inhibited cell proliferation and migration in colon cancer cells, whereas CUL7 overexpression exhibited oncogenic properties. Moreover, Cul7 -deplete mice exhibit a lower level of tumor growth. Mechanistically, CUL7 interacts with Kelch-like ECH-associated protein 1 (KEAP1) and catalyzes K29- and K48-linked polyubiquitination to promote its proteasomal degradation, which is crucial for NRF2 signaling. This leads to the decline of reactive oxygen species (ROS) and promotion of cancer growth. Importantly, the C-terminus of CUL7 is a crucial for governing KEAP1 stability and orchestrating antioxidant defense and cell growth. Clinical analysis identifies an inverse correlation between CUL7 and KEAP1 expression, and a positive correlation between CUL7 and NRF2 levels in human colon cancer. Our findings indicate that CUL7 mediates NRF2 signaling through promoting the KEAP1 ubiquitination, a mechanism that is integral to colon cancer progression. Collectively, these results establish CUL7 as a potential therapeutic target for colon cancer.
- 8 June 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Open AccessCUL7-mediated KEAP1 ubiquitination promotes the progression of colon cancer via NRF2 signaling
Cullin7 (CUL7) mediates cancer progression across multiple cancer types through its regulatory role in protein ubiquitination. However, the biological function and molecular mechanisms underlying CUL7 in colon cancer remain poorly defined. Here, we demonstrate that high CUL7 expression correlates with poor prognosis in patients. Ablation of CUL7 inhibited cell proliferation and migration in colon cancer cells, whereas CUL7 overexpression exhibited oncogenic properties. Moreover, Cul7 -deplete mice exhibit a lower level of tumor growth. Mechanistically, CUL7 interacts with Kelch-like ECH-associated protein 1 (KEAP1) and catalyzes K29- and K48-linked polyubiquitination to promote its proteasomal degradation, which is crucial for NRF2 signaling. This leads to the decline of reactive oxygen species (ROS) and promotion of cancer growth. Importantly, the C-terminus of CUL7 is a crucial for governing KEAP1 stability and orchestrating antioxidant defense and cell growth. Clinical analysis identifies an inverse correlation between CUL7 and KEAP1 expression, and a positive correlation between CUL7 and NRF2 levels in human colon cancer. Our findings indicate that CUL7 mediates NRF2 signaling through promoting the KEAP1 ubiquitination, a mechanism that is integral to colon cancer progression. Collectively, these results establish CUL7 as a potential therapeutic target for colon cancer.
- Open Access
- 14 April 2026
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 24 (1)
Synthetic embryos: current progress, application and challenges
Synthetic embryos, generated using stem cells or reprogrammed somatic cells, could recapitulate embryo development in vitro and provide unique opportunitie
- 14 April 2026
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 24 (1)
Open AccessSynthetic embryos: current progress, application and challenges
Synthetic embryos, generated using stem cells or reprogrammed somatic cells, could recapitulate embryo development in vitro and provide unique opportunitie
- 10 April 2026
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1872 (6) , 168260
The tumor suppressive role of KEAP1: Underlying mechanisms and therapeutic implications
- 10 April 2026
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1872 (6) , 168260
The tumor suppressive role of KEAP1: Underlying mechanisms and therapeutic implications
- Open Access
- 25 February 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1750289
Porcine cells restrict human cell proliferation via cellular competition in a human-porcine mesenchymal stem cells co-culture model
The xenotransplantation of human cells into porcine hosts holds immense potential in the fields of regenerative medicine and organ transplantation. However, the low survival rate of human-derived cells within porcine remains a critical bottleneck constraining the application of xenotransplantation. Whether porcine cells exert negative effect on human cell growth is not studied. Here, we established an in vitro direct co-culture model of human and porcine mesenchymal stem cells (hMSCs and pMSCs) to investigate the competitive relationship between human and porcine-derived cells. The results demonstrated that the proliferation capability of hMSCs in the co-culture system was significantly suppressed compared to those cultured in isolation. Moreover, an increasing number of pMSCs exhibited enhanced inhibition of hMSC proliferation. Notably, results from transwell assays and treatment with porcine-conditioned medium indicated that the inhibition of hMSCs by pMSCs was not mediated through soluble cytokines. To elucidate the underlying molecular mechanisms, RNA sequencing analysis was performed and the result revealed that direct co-culture significantly downregulated the expression of proliferation-related genes in hMSCs, including CYP1B1 , SLC7A11 , TFAP2C , and PSAT1 . Concurrently, the co-culture paradigm disrupted endoplasmic reticulum function and multiple amino acid transport processes within hMSCs, while activating the NF-κB signaling pathway, thereby achieving negative regulation of hMSC proliferation. Collectively, our primary study characterized the competitive interactions between hMSCs and pMSCs and uncovered possible underlying mechanisms which provided new experimental foundations for improving human cell survival in porcine hosts to advance xenotransplantation application.
- 25 February 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1750289
Open AccessPorcine cells restrict human cell proliferation via cellular competition in a human-porcine mesenchymal stem cells co-culture model
The xenotransplantation of human cells into porcine hosts holds immense potential in the fields of regenerative medicine and organ transplantation. However, the low survival rate of human-derived cells within porcine remains a critical bottleneck constraining the application of xenotransplantation. Whether porcine cells exert negative effect on human cell growth is not studied. Here, we established an in vitro direct co-culture model of human and porcine mesenchymal stem cells (hMSCs and pMSCs) to investigate the competitive relationship between human and porcine-derived cells. The results demonstrated that the proliferation capability of hMSCs in the co-culture system was significantly suppressed compared to those cultured in isolation. Moreover, an increasing number of pMSCs exhibited enhanced inhibition of hMSC proliferation. Notably, results from transwell assays and treatment with porcine-conditioned medium indicated that the inhibition of hMSCs by pMSCs was not mediated through soluble cytokines. To elucidate the underlying molecular mechanisms, RNA sequencing analysis was performed and the result revealed that direct co-culture significantly downregulated the expression of proliferation-related genes in hMSCs, including CYP1B1 , SLC7A11 , TFAP2C , and PSAT1 . Concurrently, the co-culture paradigm disrupted endoplasmic reticulum function and multiple amino acid transport processes within hMSCs, while activating the NF-κB signaling pathway, thereby achieving negative regulation of hMSC proliferation. Collectively, our primary study characterized the competitive interactions between hMSCs and pMSCs and uncovered possible underlying mechanisms which provided new experimental foundations for improving human cell survival in porcine hosts to advance xenotransplantation application.
- Open Access
- 2 April 2025
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 12
Testicular tissue cryopreservation and transplantation as a strategy for feline conservation: a review of research advances
As we humans continue our detrimental activities on the planet, the biodiversity loss is now seen as a big threat to entire ecosystem in which we all live. This issue becomes even more critical as we see a rapid increase in the number of animal species being listed as endangered, and a far greater rate of species extinction. We all know that felines play a crucial part in our ecosystems, it is therefore safe to argue that their conservation could play an important role in minimizing the biodiversity loss. Advanced reproductive biotechnologies including testicular tissue cryopreservation and transplantation are considered as effective tools for the conservation of animal species. As we have seen with the Giant Panda, these biotechnologies could offer new possibilities for the conservation of other endangered species including felines. Although previously a few wild feline spp. were conserved by this method, little is known about the factors influencing the efficiency of these methods. Therefore, if we are to maximize the conservation efforts, further optimization of these biotechnologies is required to achieve better conservation results. In this article, we present an overview of testicular tissue of felines and the factors influencing testicular tissue cryopreservation and testicular graft recovery in felines.
- 2 April 2025
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 12
Open AccessTesticular tissue cryopreservation and transplantation as a strategy for feline conservation: a review of research advances
As we humans continue our detrimental activities on the planet, the biodiversity loss is now seen as a big threat to entire ecosystem in which we all live. This issue becomes even more critical as we see a rapid increase in the number of animal species being listed as endangered, and a far greater rate of species extinction. We all know that felines play a crucial part in our ecosystems, it is therefore safe to argue that their conservation could play an important role in minimizing the biodiversity loss. Advanced reproductive biotechnologies including testicular tissue cryopreservation and transplantation are considered as effective tools for the conservation of animal species. As we have seen with the Giant Panda, these biotechnologies could offer new possibilities for the conservation of other endangered species including felines. Although previously a few wild feline spp. were conserved by this method, little is known about the factors influencing the efficiency of these methods. Therefore, if we are to maximize the conservation efforts, further optimization of these biotechnologies is required to achieve better conservation results. In this article, we present an overview of testicular tissue of felines and the factors influencing testicular tissue cryopreservation and testicular graft recovery in felines.
- Open Access
- 6 March 2025
- Published by Elsevier in Gynecologic Oncology
- Vol. 195, 34-44
Research advances CRISPR gene editing technology generated models in the study of epithelial ovarian carcinoma
- 6 March 2025
- Published by Elsevier in Gynecologic Oncology
- Vol. 195, 34-44
Open AccessResearch advances CRISPR gene editing technology generated models in the study of epithelial ovarian carcinoma